A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study)

Jacek Legutko,Wojciech Zasada,Grzegorz L. Kaluza,Grzegorz Heba,Lukasz Rzeszutko,Jacek Jakala,Jacek Dragan,Artur Klecha,Dawid Giszterowicz,Wojciech Dobrowolski,Łukasz Partyka,Swaminathan Jayaraman,Dariusz Dudek

A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study)

2013

Jacek Legutko
Wojciech Zasada
Grzegorz L. Kaluza
Grzegorz Heba
Lukasz Rzeszutko
Jacek Jakala
Jacek Dragan
Artur Klecha
Dawid Giszterowicz
Wojciech Dobrowolski
Łukasz Partyka
Swaminathan Jayaraman
Dariusz Dudek

Aims Evaluation of safety and efficacy of ProNOVA XR, a new generation of polymer-free sirolimus eluting stents (SES), utilizing a pharmaceutical excipient for timed release of sirolimus from the XR platform.

Keywords:

Artery
Sirolimus
Comorbidity
Prospective cohort study
Coronary artery disease
Coronary stent
Surgery
Pharmaceutical Excipient
Medicine
Cardiology
Internal medicine
polymer free
treatment outcome
clinical evaluation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations